Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Trivano
Alles over “Biotechnologie”
Aandelen in “Biotechnologie”
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Aandeel
Datum
Koers
Evolutie
Even geduld...
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Nieuws over “Biotechnologie”
Toon enkel gratis nieuws
05:45 ·
Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
· Persbericht
05:45 ·
Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
· Persbericht
00:46 ·
FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER
· Persbericht
16/05 ·
BLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuit
· Persbericht
16/05 ·
Monthly information on share capital and company voting rights
· Persbericht
16/05 ·
DBV Technologies Announces Results of its 2024 Combined General Meeting
· Persbericht
16/05 ·
Voting Rights and Shares Capital of the Company
· Persbericht
16/05 ·
Galapagos creates new subscription right plans
· Persbericht
16/05 ·
Galapagos creëert nieuwe inschrijvingsrechtenplannen
· Persbericht
16/05 ·
Inventiva announces the positive recommendation of the fourth DMC of the NATiV3 Phase III clinical trial with lanifibranor in patients with MASH/NASH
· Persbericht
16/05 ·
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
· Persbericht
16/05 ·
Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
· Persbericht
16/05 ·
Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
· Persbericht
16/05 ·
Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
· Persbericht
16/05 ·
Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice
· Persbericht
16/05 ·
Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, a Novel HER2-Targeting CAR-Monocyte
· Persbericht
16/05 ·
Compugen Publishes Paper in Cancer Immunology Research on Unique Biology of PVRIG and its Therapeutic Potential
· Persbericht
16/05 ·
Ionis announces positive topline results from Phase 1/2a trial of ION582 for Angelman syndrome
· Persbericht
16/05 ·
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
· Persbericht
16/05 ·
Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders
· Persbericht
16/05 ·
AMGEN TO HOST CONFERENCE CALL FOLLOWING ATS 2024
· Persbericht
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe